These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1470566)

  • 1. Effects of peptide YY on pancreatic blood flow and oxygen consumption.
    Pawlik WW; Gustaw P; Sendur R; Czarnobilski K; Hottenstein OD; Konturek SJ
    Pol J Pharmacol Pharm; 1992; 44(3):289-98. PubMed ID: 1470566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of cholecystokinin receptors in the regulation of the circulation and oxygen consumption in the pancreas].
    Gustaw P; Samborska M; Pawlik WW; Konturek SJ
    Folia Med Cracov; 1990; 31(1-2):45-56. PubMed ID: 2210484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide as mediator of bradykinin-induced pancreatic circulatory and metabolic responses.
    Pawlik WW; Sendur R; Biernat J; KozioĊ‚ R
    J Physiol Pharmacol; 1997 Dec; 48(4):751-60. PubMed ID: 9444622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nitric oxide in the pancreatic vascular and metabolic responses associated with activation of capsaicin-sensitive neurons.
    Pawlik WW; Czarnobilski K; Sendur R; Konturek SJ
    J Physiol Pharmacol; 1996 Dec; 47(4):601-9. PubMed ID: 9116327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental studies on the interrelationship between organs mediated by peptide YY: effect on splanchnic circulation and exocrine pancreas in dogs.
    Sumi S; Inoue K; Tobe T
    Nihon Geka Hokan; 1990 May; 59(3):224-33. PubMed ID: 2130785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic pathway in the inhibition of pancreatic secretion by peptide YY in dogs.
    Konturek SJ; Bilski J; Pawlik W; Tasler J; Domschke W
    Gastroenterology; 1988 Feb; 94(2):266-73. PubMed ID: 3335306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pancreatic polypeptide and peptide YY on pancreatic blood flow and pancreatic exocrine secretion in the anesthetized dog.
    DeMar AR; Lake R; Fink AS
    Pancreas; 1991 Jan; 6(1):9-14. PubMed ID: 1994383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide YY inhibits pancreatic secretion via cholinergic pathways.
    Brodish RJ; Kuvshinoff BW; Fink AS; McFadden DW
    J Surg Res; 1993 Jul; 55(1):103-8. PubMed ID: 8105149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic peptide YY mRNA levels increase during adaptation after small intestinal resection.
    Liu CD; Hines OJ; Whang EE; Laird EC; Skotzko MJ; Zinner MJ; Ashley SW; McFadden DW
    J Surg Res; 1995 Jan; 58(1):6-11. PubMed ID: 7830408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide YY antagonizes beta-adrenergic-stimulated release of insulin in dogs.
    Greeley GH; Lluis F; Gomez G; Ishizuka J; Holland B; Thompson JC
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E513-7. PubMed ID: 2895586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1.
    Liu CD; Balasubramaniam A; Saxton RE; Paiva M; McFadden DW
    J Surg Res; 1995 Jun; 58(6):707-12. PubMed ID: 7791350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic pathways do not mediate peptide YY-induced inhibition of pancreatic exocrine secretion.
    Brodish RJ; Kuvshinoff BW; McFadden DW; Fink AS
    Pancreas; 1995 Mar; 10(2):187-93. PubMed ID: 7716143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of peptide YY on dog and rat pancreatic secretion in vivo and in vitro.
    Bilski J; Hladij M; Jaworek J; Konturek SJ; Varga G
    Int J Pancreatol; 1988 Jul; 3(5):309-21. PubMed ID: 2459272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory action of peptide YY on pancreatic secretion is independent of secretin.
    Lluis F; Gomez G; Greeley GH; Thompson JC
    Biol Signals; 1992; 1(2):88-93. PubMed ID: 1307917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial peptide YY release is mediated by cholecystokinin.
    McFadden DW; Rudnicki M; Kuvshinoff B; Fischer JE
    Surg Gynecol Obstet; 1992 Aug; 175(2):145-50. PubMed ID: 1636140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.
    van den Hoek AM; Heijboer AC; Voshol PJ; Havekes LM; Romijn JA; Corssmit EP; Pijl H
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E238-45. PubMed ID: 16940471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pancreas and oxygen consumption. 1. Pancreatic oxygen consumption in normo- and hypovolemic dogs.
    Robert JH; Toledano AE; Huang G; Toth LS; Premus G; Papp M; Dreiling DA
    Int J Pancreatol; 1989 Feb; 4(1):51-63. PubMed ID: 2926179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide YY attenuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42J.
    Robinson K; Vona-Davis L; Riggs D; Jackson B; McFadden D
    J Am Coll Surg; 2006 May; 202(5):788-96. PubMed ID: 16648019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of natural peptide YY on blood flow and exocrine secretion of pancreas in dogs.
    Inoue K; Hosotani R; Tatemoto K; Yajima H; Tobe T
    Dig Dis Sci; 1988 Jul; 33(7):828-32. PubMed ID: 3378477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intraluminal peptide YY on pancreatic function.
    Brodish RJ; Kuvshinoff BW; Fink AS; McFadden DW
    Int J Pancreatol; 1992 Oct; 12(2):153-60. PubMed ID: 1460330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.